- Report
- June 2022
- 140 Pages
Global
From €4502EUR$4,750USD£3,761GBP
Otitis Media is a type of ear infection that affects the middle ear and is a common condition in children. It is caused by a bacterial or viral infection and can lead to hearing loss, pain, and other complications. Allergy and Immunology specialists are often involved in the diagnosis and treatment of Otitis Media. Treatment typically involves antibiotics, decongestants, and anti-inflammatory medications. In some cases, surgery may be necessary to remove fluid from the middle ear.
The Otitis Media market is a growing segment of the Allergy and Immunology industry. Companies in this market are focused on developing treatments and therapies to address the symptoms and complications of Otitis Media. These treatments range from medications to surgical procedures. Additionally, companies are researching new methods of diagnosis and prevention of Otitis Media.
Some companies in the Otitis Media market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, and Sanofi. Show Less Read more